| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $310.9M | +7.1% |
| R&D Expense | $70.3M | +11.0% |
| SG&A Expense | $45.1M | +11.9% |
| Operating Income | -$10.5M | +62.7% |
| Pre-tax Income | -$2.5M | +89.3% |
| Income Tax | $16.9M | +389.2% |
| Net Income | -$19.4M | -9.1% |
| EPS (Basic) | -$0.15 | -7.1% |
| EPS (Diluted) | -$0.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.9M | -0.8% |
| Current Assets | $174.9M | -0.6% |
| Total Assets | $366.3M | +4.1% |
| Current Liabilities | $46.0M | +34.8% |
| Total Liabilities | $78.0M | +56.9% |
| Stockholders' Equity | $288.4M | -4.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.7M | +54.9% |
| Capital Expenditures | $6.3M | -47.1% |
| Investing Cash Flow | -$32.3M | +68.4% |
| Financing Cash Flow | -$20.2M | -110.9% |
| Free Cash Flow | $45.4M | +112.0% |
| -7.1% |